AdaptHealth (NASDAQ:AHCO – Get Rating) had its price objective trimmed by Robert W. Baird from $23.00 to $20.00 in a research note released on Wednesday morning, The Fly reports.
A number of other analysts have also weighed in on the stock. Bank of America lowered shares of AdaptHealth from a buy rating to a neutral rating and dropped their target price for the stock from $21.00 to $12.00 in a report on Tuesday. Deutsche Bank Aktiengesellschaft lowered shares of AdaptHealth from a buy rating to a hold rating and lowered their price objective for the stock from $28.00 to $11.30 in a report on Wednesday. TheStreet lowered shares of AdaptHealth from a c- rating to a d+ rating in a report on Thursday, April 6th. SVB Securities lowered their price objective on shares of AdaptHealth from $30.00 to $23.00 in a report on Wednesday, March 1st. Finally, Stifel Nicolaus lowered shares of AdaptHealth from a buy rating to a hold rating and lowered their price objective for the stock from $18.00 to $11.00 in a report on Tuesday. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and an average target price of $19.04.
AdaptHealth Stock Performance
AdaptHealth stock opened at $11.06 on Wednesday. The company has a current ratio of 1.28, a quick ratio of 1.00 and a debt-to-equity ratio of 1.00. The firm has a 50-day moving average of $12.77 and a 200-day moving average of $18.16. The firm has a market cap of $1.49 billion, a P/E ratio of 42.54, a P/E/G ratio of 0.64 and a beta of 0.66. AdaptHealth has a 1-year low of $10.21 and a 1-year high of $27.48.
Hedge Funds Weigh In On AdaptHealth
Institutional investors and hedge funds have recently made changes to their positions in the business. Versant Capital Management Inc bought a new position in shares of AdaptHealth during the third quarter valued at approximately $26,000. Mesirow Institutional Investment Management Inc. purchased a new position in AdaptHealth in the 1st quarter worth approximately $25,000. Tower Research Capital LLC TRC raised its holdings in AdaptHealth by 610.0% in the 1st quarter. Tower Research Capital LLC TRC now owns 3,394 shares of the company’s stock worth $42,000 after acquiring an additional 2,916 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in AdaptHealth by 49.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 3,675 shares of the company’s stock worth $71,000 after acquiring an additional 1,209 shares during the last quarter. Finally, Group One Trading L.P. raised its holdings in AdaptHealth by 134.3% in the 1st quarter. Group One Trading L.P. now owns 3,720 shares of the company’s stock worth $60,000 after acquiring an additional 2,132 shares during the last quarter. Institutional investors own 86.33% of the company’s stock.
AdaptHealth Company Profile
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs.
Further Reading
- Get a free copy of the StockNews.com research report on AdaptHealth (AHCO)
- Occidental Petroleum: Will Buffet Buy More?
- 5 Best Healthcare Sector ETFs
- Electronic Arts Has Game But Can Share Price Move Higher?
- Wendy’s May Have Just Become A Value Play
- Rivian Leads EV Startups But Will The Stock Move Higher?
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
